Is Adherence to Erythrocytes a Factor in Extrapulmonary Dissemination?
article has not abstract
Published in the journal:
. PLoS Pathog 6(12): e32767. doi:10.1371/journal.ppat.1001219
Category:
Opinion
doi:
https://doi.org/10.1371/journal.ppat.1001219
Summary
article has not abstract
Mycoplasma pneumoniae is one of the most common causes of respiratory infections in children and adults worldwide [1], [2]. This bacterial pathogen is estimated to be responsible for at least one case of pneumonia per 1,000 persons and >100,000 adult hospitalizations per year in the United States alone [1]–[3]. The infection is mostly mild, but all age groups can experience more severe disease, and fatal cases occasionally occur.
Extrapulmonary manifestations are a notable aspect of M. pneumoniae infections and are seen in up to 25% of infected persons [1], [2], [4]. It has been pointed out that the high prevalence of M. pneumoniae infection in most populations predisposes to reporting concurrent but perhaps unrelated events as if they were part of the disease [2], and this may be so particularly for single case reports confirmed only by serologic response [1], [2]. Among reported extrapulmonary manifestations, joint, skin, hematologic, cardiovascular, nervous, and immune system disorders are solidly documented by culture, polymerase chain reaction (PCR), immunohistochemical analysis, and/or serologic analysis [1], [2], [4]–[7].
Characteristics of M. pneumoniae suggest the possibility that this mycoplasma could adhere to erythrocytes during extrapulmonary dissemination and such adherence could contribute to pathogenesis. First, M. pneumoniae has been cultured from extrapulmonary infection sites such as synovial fluid and pericardial fluid [1], [2], [4], so reaching such sites demonstrates that M. pneumoniae must be able to enter the blood stream. Second, it has long been known that M. pneumoniae adheres to human erythrocytes in vitro [8], [9], and electron microscopy shows M. pneumoniae does not merely adhere to erythrocytes but deforms them by producing depressions in the erythrocyte surface in which the mycoplasmas adhere closely [10]. Third, M. pneumoniae belongs to the same phylogenetic group that contains the hemotropic mycoplasmas; these uncultivated mycoplasmas parasitize erythrocytes of mammalian hosts and produce acute and chronic blood infections with hemolytic anemia and other illness [11]. Hemotropic mycoplasmas deform host erythrocytes and produce depressions in which they also adhere closely, and it is striking that the erythrocyte adherence of M. pneumoniae seen in vitro [10] appears to be identical to that observed in hemotropic mycoplasma erythrocyte infections [12]. Further, M. pneumoniae famously causes half or more of patients to produce erythrocyte cold agglutinins, and this character also is shared with hemotropic mycoplasmas [11]. We note that there is a report that a hemotropic mycoplasma can invade erythrocytes [13].
Some notion of the frequency of blood entry by M. pneumoniae may be provided by PCR studies that have demonstrated M. pneumoniae DNA in serum [14]–[16]. M. pneumoniae DNA has been detected in sera from pediatric patients both with pneumonia (1/25) and, significantly, without pneumonia (10/17), and in some cases M. pneumoniae DNA was detected for periods of more than 20 days, suggesting a bacteremia [14]. A real-time PCR study that utilized archival sera mainly from adults found M. pneumoniae DNA in 15 of 29 seropositive patient sera [16]. If these findings and other PCR reports detecting M. pneumoniae DNA in interior tissues often reflects the presence of organisms, as is thought by many investigators, then blood entry by M. pneumoniae might not be rare.
It may be necessary, nonetheless, to examine blood from a number of patients because of variables that could affect the presence of M. pneumoniae in a given sample. These include the frequency with which infection leads to blood entry, the infection stage(s) during which M. pneumoniae may enter the blood, the dwell period in blood, and the patient's immune status. The genotype of the infecting strain [17]–[20] also could be a factor in blood entry.
Rapid identification of M. pneumoniae infections by PCR [21]–[23] permits selection of appropriate cases for investigating the possibility that M. pneumoniae adheres to patient erythrocytes. The following information about hemotropic mycoplasma infections may be helpful in examining this possibility. Hemotropic mycoplasma infections have been detected mainly by visual search for erythrocyte-attached mycoplasmas in Wright-Giemsa blood smears, a relatively insensitive method, by animal inoculation, and by PCR (the current standard), but also of course by other molecular biological and instrument-based methods, including fluorescent-activated cell sorting. The percentage of infected erythrocytes in stained smears can vary from extremely high values (one or more mycoplasmas are seen attached to nearly every erythrocyte in most microscope fields) to very low values (searches of replicate smears from a PCR positive blood are negative), depending on, importantly, not only the stage of the infection but also the Mycoplasma species. Immuofluorescent or DNA staining substantially improves visual searching, and fluorescent staining allows more sensitive examination of archival Wright-Giemsa stained slides [24]. Specific staining also permits identification of mycoplasmas free in the plasma that by light microscopy might be mistaken for nonbacterial particles.
Obtaining proof that M. pneumoniae has the ability to adhere to patient erythrocytes would enlarge our understanding of M. pneumoniae pathogenicity and provide an intriguing new perspective on how this mycoplasma disseminates in the bloodstream to produce extrapulmonary disease.
Zdroje
1. WaitesKB
TalkingtonDF
2004
Mycoplasma pneumoniae and its role as a human pathogen.
Clin Microbiol Rev
17
697
728
2. BaumSJ
2005
Mycoplasma pneumoniae and atypical pneumonia.
Bennett's principles and practice of infectious diseases.
MandellD
Philadelphia
Elsevier
2271
2280
3. LauderdaleTL
ChangFY
BenRJ
YinHC
NiYH
2005
Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.
Respir Med
99
1079
1086
4. StammB
MoschopulosM
HungerbuehlerH
GuarnerJ
GenrichGI
2008
Neuroinvasion by Mycoplasma pneumoniae in acute disseminated encephalomyelitis.
Emerg Infect Dis
14
641
643
5. NaritaM
2010
Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.
J Infect Chemother
16
162
169
6. AtkinsonTP
BalishMF
WaitesKB
2008
Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections.
FEMS Microbiol Rev
32
956
973
7. WaitesKB
BalishMF
AtkinsonTP
2008
New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.
Future Microbiol
3
635
648
8. MancheeRJ
Taylor-RobinsonD
1968
Haemadsorption and haemagglutination by mycoplasmas.
J Gen Microbiol
50
465
478
9. BasemanJB
BanaiM
KahaneI
1982
Sialic acid residues mediate Mycoplasma pneumoniae attachment to human and sheep erythrocytes.
Infect Immun
38
389
391
10. DeasJE
JanneyFA
LeeLT
HoweC
1979
Immune electron microscopy of cross-reactions between Mycoplasma pneumoniae and human erythrocytes.
Infect Immun
24
211
217
11. NeimarkH
JohanssonKE
RikihisaY
TullyJG
2001
Proposal to transfer some members of the genera Haemobartonella and Eperythrozoon to the genus Mycoplasma with descriptions of ‘Candidatus Mycoplasma haemofelis’, ‘Candidatus Mycoplasma haemomuris’, ‘Candidatus Mycoplasma haemosuis’ and ‘Candidatus Mycoplasma wenyonii’.
Int J Syst Evol Microbiol
51
891
899
12. NeimarkH
BarnaudA
GounonP
MichelJC
ContaminH
2002
The putative haemobartonella that influences Plasmodium falciparum parasitaemia in squirrel monkeys is a haemotropic mycoplasma.
Microbes Infect
4
693
698
13. GroebelK
HoelzleK
WittenbrinkMM
ZieglerU
HoelzleLE
2009
Mycoplasma suis invades porcine erythrocytes.
Infect Immun
77
576
584
14. NaritaM
MatsuzonoY
ItakuraO
TogashiT
KikutaH
1996
Survey of mycoplasmal bacteremia detected in children by polymerase chain reaction.
Clin Infect Dis
23
522
525
15. NaritaM
YamadaS
NakayamaT
SawadaH
NakajimaM
2001
Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia.
J Infect
42
154
156
16. DaxboeckF
KhanakahG
BauerC
StadlerM
HofmannH
2005
Detection of Mycoplasma pneumoniae in serum specimens from patients with mycoplasma pneumonia by PCR. Int J Med Microbiol 295: 279-285.
Erratum: Int J Med Microbiol 2006;
55
17. Dorigo-ZetsmaJW
DankertJ
ZaatSA
2000
Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups.
J Clin Microbiol
38
965
970
18. KenriT
OkazakiN
YamazakiT
NaritaM
IzumikawaK
2008
Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains.
J Med Microbiol
57
469
475
19. DumkeR
Von BaumH
LückPC
JacobsE
2010
Subtypes and variants of Mycoplasma pneumoniae: local and temporal changes in Germany 2003-2006 and absence of a correlation between the genotype in the respiratory tract and the occurrence of genotype-specific antibodies in the sera of infected patients.
Epidemiol Infect
25
1
9
20. HansenEJ
WilsonRM
BasemanJB
1979
Isolation of mutants of Mycoplasma pneumoniae defective in hemadsorption.
Infect Immun
23
903
906
21. WinchellJM
ThurmanKA
MitchellSL
ThackerWL
FieldsBS
2008
Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation.
J Clin Microbiol
46
3116
3118
22. TouatiA
BenardA
Ben HassenA
BébéarCM
PereyreS
2009
Evaluation of five commercial real-time PCR assays for the detection of Mycoplasma pneumoniae in respiratory tract specimens.
J Clin Microbiol
47
2268
2271
23. DumkeR
JacobsE
2009
Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.
J Clin Microbiol
47
441
444
24. KobayashiY
KimuraS
TanakaK
WadaK
OzawaM
1991
Shift in the megakaryocyte ploidy in MDS patients: microcytofluorometry with DAPI staining after destaining of Wright-Giemsa stain.
Br J Haematol
79
556
561
Štítky
Hygiena a epidemiologie Infekční lékařství LaboratořČlánek vyšel v časopise
PLOS Pathogens
2010 Číslo 12
- Perorální antivirotika jako vysoce efektivní nástroj prevence hospitalizací kvůli COVID-19 − otázky a odpovědi pro praxi
- Stillova choroba: vzácné a závažné systémové onemocnění
- Diagnostický algoritmus při podezření na syndrom periodické horečky
- Jak souvisí postcovidový syndrom s poškozením mozku?
- Diagnostika virových hepatitid v kostce – zorientujte se (nejen) v sérologii
Nejčtenější v tomto čísle
- HIV-1 Envelope Subregion Length Variation during Disease Progression
- Coming of Age—Sexual Reproduction in Species
- Evidence That Intracellular Stages of Utilize Amino Sugars as a Major Carbon Source
- Compartmentation of Redox Metabolism in Malaria Parasites